Search results
Emily Blunt Introduces Kelly Clarkson to Her Favorite Candy of All Time: ‘Light as Air’
People Magazine· 3 days agoEmily Blunt is very protective of her favorite candy. During the May 8 episode of The Kelly Clarkson...
Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target Increased to $60.00 by Analysts at Oppenheimer
ETF DAILY NEWS· 1 day agoCorbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report) had its target price upped by equities research analysts at Oppenheimer from $58.00 to $60.00 in a research report issued ...
Rachael Harris Says She and Tom Ellis Have Discussed Doing a 'Lucifer' Rewatch Podcast (Exclusive)
ET Online via AOL· 2 days ago"I said, 'Tom, let's do a rewatch Lucifer podcast!'"According to Harris, Ellis is considering the...
Milwaukee Bucks dismiss three assistant coaches
Gannett via AOL· 13 hours agoFollowing further evaluation over the last week, the Journal Sentinel confirmed the Bucks dismissed assistant coaches Josh Oppenheimer, Sidney Dobner and...
Oppenheimer Lowers Aptiv (NYSE:APTV) Price Target to $145.00
ETF DAILY NEWS· 6 days agoAptiv (NYSE:APTV – Get Free Report) had its target price lowered by stock analysts at Oppenheimer...
BorgWarner (NYSE:BWA) Given New $40.00 Price Target at Oppenheimer
ETF DAILY NEWS· 4 days agoBorgWarner (NYSE:BWA – Free Report) had its target price increased by Oppenheimer from $39.00 to $40.00 in a report published on Friday morning, Benzinga reports. StockNews.com ...
Q1 2024 Oncternal Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoCarl Byrnes; Analyst; Northland Capital Markets Hartaj Singh; Analyst; Oppenheimer & Co. Inc. Robert Burns; Analyst; HC Wainwright Kemp Dolliver; Analyst; Brookline Capital ...
Q1 2024 Cannae Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 19 hours ago(Operator Instructions) ...
Brainsway shares target raised by Oppenheimer citing strong sales By Investing.com
Investing.com· 2 days agoThursday, May 9, 2024, saw Brainsway (NASDAQ:BWAY) shares receive a boost to its price target, with ...
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 2.1% After Analyst Downgrade
ETF DAILY NEWS· 11 hours agoCRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) shares dropped 2.1% during trading on Friday after Oppenheimer lowered their price target on the stock from $102.00 ...
